ArticleProceedings of the National Academy of Sciences of the United States of America2012

Lung cancers with acquired resistance to EGFR inhibitors occasionally harbor BRAF gene mutations but lack mutations in KRAS, NRAS, or MEK1.

Kadoaki Ohashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.